Sleep solution developer Eight Sleep has raised $100m in a funding round to support the development of its AI-powered Sleep Agent solution and pursue approval from the US Food and Drug Administration (FDA) for its health-focused applications.
The round received contributions from investors, including HSG, Atreides, Valour Equity Partners, Founders Fund, Y Combinator, and sports personalities.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
With the fresh influx of capital, Eight Sleep is set to enhance its AI capabilities, starting with the Sleep Agent.
This initiative represents a leap in the application of large language models to human physiology, moving beyond simple dialogue to provide actionable, real-time optimisation.
According to the company, the Sleep Agent will interpret biometric data and create digital simulations for each user, enabling it to forecast outcomes with modelling techniques.
It will be able to alter factors such as bed elevation, pre-sleep rituals and temperature to maximise nightly recovery.
US Tariffs are shifting - will you react or anticipate?
Don鈥檛 let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataBuilding on Eight Sleep’s current Autopilot feature, which adjusts nightly settings based on user biofeedback and behaviour, the funding will also facilitate the company鈥檚 expansion into the medical domain.
Capitalising on the health monitoring offerings of Eight Sleep’s Pod solution, which can track respiratory and cardiovascular patterns, the company is developing AI solutions for medical sleep challenges, initially focusing on sleep apnoea and menopausal sleep disturbances.
Eight Sleep CEO and co鈥慺ounder Matteo Franceschetti said: 鈥淓ight Sleep has developed a turn-key solution for sleep and health optimisation: hardware, software, AI, and consumer goods that dynamically adjust around each person鈥檚 needs.
鈥淭his new funding enables us to accelerate the deployment of AI for sleep optimisation, expand into medical applications like menopausal sleep and sleep apnoea, and bring our technology to millions of people around the world.鈥�
The company recently introduced Hot Flash Mode, a dynamic cooling feature to help relieve symptoms related to menopause.
The company’s next step is to develop intelligent interventions targeting sleep apnoea, leveraging the contactless biometric monitoring and real-time actuations of Pod.
